These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 212377)

  • 41. Induction of Epstein-Barr virus early antigen by phytohaemagglutinin in the presence of 5-iodo-2'-deoxyuridine: application to EBV serology.
    Lenoir G; Tovey MG; Lavoue MF
    J Immunol Methods; 1980; 34(1):23-9. PubMed ID: 6252264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,
    Dalianis T; Klein G; Andersson B
    Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.
    Anisimová E; Prachová K; Roubal J; Vonka V
    Arch Virol; 1984; 81(3-4):223-37. PubMed ID: 6089703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction.
    Patarroyo M; Blazar B; Pearson G; Klein E; Klein G
    Int J Cancer; 1980 Sep; 26(3):365-71. PubMed ID: 6270007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
    Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
    Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells.
    Ito Y; Kawanishi M; Harayama T; Takabayashi S
    Cancer Lett; 1981 Apr; 12(3):175-80. PubMed ID: 6266651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.
    Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H
    Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
    Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
    Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines.
    Lidin BI; Lamon EW; Cloud G; Soong SJ
    Intervirology; 1982; 18(1-2):66-75. PubMed ID: 6288617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
    Glaser R; Tarr KL; Dangel AW
    Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
    Blazar B; Patarroyo M; Klein E; Klein G
    J Exp Med; 1980 Mar; 151(3):614-27. PubMed ID: 6244358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
    Lidin B; Lamon EW
    Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
    Tovey MG; Dron M; Gresser I
    J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection.
    Alfieri C; Ghibu F; Joncas JH
    Can Med Assoc J; 1984 Nov; 131(10):1249-52. PubMed ID: 6093976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
    Moar MH; Klein G
    Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of Epstein-Barr virus by an new tumor promoter, teleocidin, compared to induction by TPA.
    Yamamoto H; Katsuki T; Hinuma Y; Hoshino H; Miwa M; Fujiki H; Sugimura T
    Int J Cancer; 1981 Aug; 28(2):125-9. PubMed ID: 6274809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of Epstein-Barr virus gene expression by other herpesviruses.
    Kikuta H; Rapp F
    Intervirology; 1988; 29(5):281-91. PubMed ID: 2848780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.